1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Why Your ISTA Shares Sold as Low as They Did

Discussion in 'Ista Pharma' started by OCI, May 25, 2013 at 4:51 PM.

Tags: Add Tags
  1. OCI

    OCI Guest

    All you ISTA shareholders who thought B&L bought you out too cheaply - here's why:


    B&L knew they were going to have to plead you out to felony charges for the misconduct of your previous management. That reduced their offering price. That reduced the amount you got for each share. In total, some $33 million.

    You need the thank your previous management for your losses. Or hold them accountable. Your decision.

  2. Anonymous

    Anonymous Guest

    OK, somebody get Vince on the phone stat! He's either on his yacht or plane.

    I'm steaming mad!!!
  3. Anonymous

    Anonymous Guest

    Yep! KKN one of your infamous managers knew all about this. Can you say dirty manager?!
    That's one of many reasons why B&L fired her.